Last reviewed · How we verify
NCT03565510
The Impact of a High-protein Diet on Energy Metabolism in Healthy Men
NA trial testing High-Protein Diet in Dietary Modification in 27 participants. Completed in 31 October 2019.
31 October 2019
Quick facts
| Lead sponsor | University of Alberta |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 27 |
| Start date | 1 August 2018 |
| Primary completion | 31 October 2019 |
| Estimated completion | 31 October 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- High-Protein Diet
Conditions studied
- Dietary Modification — all drugs for Dietary Modification →
Sponsor
University of Alberta
Who can join
Adults 18 to 35, male only, with Dietary Modification. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the impact of a high-protein diet (achieved with the use of a nutritional supplement, Almased®) versus a diet of a typical North American macronutrient distribution on energy metabolism, metabolic blood markers and appetite sensations. This study will be a randomized, controlled, cross-over trial of an acute nutritional intervention. A total of 20 participants will be randomly assigned (1:1) to one of the following groups: * Control group (CON). * High protein diet group (HP). The diets given to participants in both groups will be eucaloric. While receiving the diets in the whole body calorimetry unit for 32 hours, participants' overall changes in energy metabolism, metabolic blood markers, and appetite sensations will be assessed.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
A high-protein total diet replacement increases energy expenditure and leads to negative fat balance in healthy, normal-weight adults.
Oliveira CLP, Boulé NG, Sharma AM, Elliott SA, et al · · 2021 · cited 17× · PMID 33247306 · DOI 10.1093/ajcn/nqaa283 -
Consumption of a High-Protein Meal Replacement Leads to Higher Fat Oxidation, Suppression of Hunger, and Improved Metabolic Profile After an Exercise Session.
Oliveira CLP, Boulé NG, Berg A, Sharma AM, et al · · 2021 · cited 14× · PMID 33466462 · DOI 10.3390/nu13010155 -
A high-protein total diet replacement alters the regulation of food intake and energy homeostasis in healthy, normal-weight adults.
Oliveira CLP, Boulé NG, Elliott SA, Sharma AM, et al · · 2022 · cited 8× · PMID 34928408 · DOI 10.1007/s00394-021-02747-1 -
Examining the effects of a high-protein total diet replacement on energy metabolism, metabolic blood markers, and appetite sensations in healthy adults: protocol for two complementary, randomized, controlled, crossover trials.
Oliveira CLP, Boulé NG, Sharma AM, Elliott S, et al · · 2019 · cited 7× · PMID 31881910 · DOI 10.1186/s13063-019-3950-y
Verify or expand the search:
- PubMed search for NCT03565510
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High-Protein Diet
Trials testing the same drug.
- NCT07314177 — Effects of Three Dietary Strategies on Body Composition and Metabolic Health in Adults With Overweight or Obesity · NA · completed
- NCT04841915 — Dairy Protien Rich Diet for NAFLD Patients · NA · completed
Other recruiting trials for Dietary Modification
Currently open trials in the same condition.
- NCT06888687 — Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes. · NA · recruiting
- NCT06590805 — Electroacupoint for Diminutive Milk Production · NA · recruiting
- NCT03681054 — Dietary Management of Gestational Diabetes · NA · active not recruiting
- NCT03667404 — Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study · Phase 2 · active not recruiting
Other University of Alberta trials
Trials by the same sponsor.
- NCT03240900 — Electrical Stimulation for Improving Postoperative Breast Sensation · NA · not yet recruiting
- NCT04231760 — The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD · Phase 1, PHASE2 · not yet recruiting
- NCT06649604 — Reducing Pain From Retinal Laser With Vibrational Stimulation · NA · not yet recruiting
- NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
- NCT06920914 — Effects of Minimally vs. Ultra-Processed Diets on Potassium (K) Handling in CKD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03565510 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alberta
- Last refreshed: 23 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03565510.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing